Skip to main content
. 2023 Apr 18;14:2213. doi: 10.1038/s41467-023-37462-4

Fig. 2. KRAS G12D variant peptide identification.

Fig. 2

a Identification of a novel peptide resulted from the KRAS G12D mutation in 10 CPTAC cohorts. b A representative MS/MS spectrum identifying the mutant peptide in a pancreatic cancer sample. The TMT reporter ion of the sample with KRAS G12D mutation evidence at DNA level (highlighted in red) shows much higher intensity than those from samples without this mutation. Source data of 2a are provided as a Source Data file.